Fijnheer R - Search Results

1

Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.

Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, Sluiter WJ, Limburg PC, Derksen RH, van de Winkel JG, Kallenberg CG. Dijstelbloem HM, et al. Among authors: fijnheer r. Arthritis Rheum. 2000 Dec;43(12):2793-800. doi: 10.1002/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6. Arthritis Rheum. 2000. PMID: 11145038 Free article.

2

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.

Fijnheer R, Horbach DA, Donders RC, Vilé H, von Oort E, Nieuwenhuis HK, Gmelig-Meijling FH, de Groot PG, Derksen RH. Fijnheer R, et al. Thromb Haemost. 1996 Oct;76(4):514-7. Thromb Haemost. 1996. PMID: 8902988

3

Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.

Fijnheer R, Roest M, Haas FJ, De Groot PG, Derksen RH. Fijnheer R, et al. J Rheumatol. 1998 Sep;25(9):1737-42. J Rheumatol. 1998. PMID: 9733454

4

Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.

Frijns R, Fijnheer R, Schiel A, Donders R, Sixma J, Derksen R. Frijns R, et al. Among authors: fijnheer r. J Rheumatol. 2001 Mar;28(3):514-9. J Rheumatol. 2001. PMID: 11296951

5

Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus.

Frijns CJ, Derksen RH, De Groot PG, Algra A, Fijnheer R. Frijns CJ, et al. Among authors: fijnheer r. Clin Exp Immunol. 2001 Jul;125(1):149-54. doi: 10.1046/j.1365-2249.2001.01520.x. Clin Exp Immunol. 2001. PMID: 11472438 Free PMC article.

6

The FcgammaRIIa-polymorphic site as a potential target for acute graft-versus-host disease in allogeneic stem cell transplantation.

van der Straaten HM, Fijnheer R, Nieuwenhuis HK, van de Winkel JG, Verdonck LF. van der Straaten HM, et al. Among authors: fijnheer r. Biol Blood Marrow Transplant. 2005 Mar;11(3):206-12. doi: 10.1016/j.bbmt.2004.12.331. Biol Blood Marrow Transplant. 2005. PMID: 15744239 Free article.

7

beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation.

Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot PG. Hulstein JJ, et al. Among authors: fijnheer r. Blood. 2007 Sep 1;110(5):1483-91. doi: 10.1182/blood-2006-10-053199. Epub 2007 May 8. Blood. 2007. PMID: 17488878 Free article. Clinical Trial.

8

Cladribine therapy for systemic mastocytosis.

Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, Van 't Wout JW, Verhoef G, Gerrits WB, van Dobbenburgh OA, Pasmans SG, Fijnheer R. Kluin-Nelemans HC, et al. Among authors: fijnheer r. Blood. 2003 Dec 15;102(13):4270-6. doi: 10.1182/blood-2003-05-1699. Epub 2003 Aug 21. Blood. 2003. PMID: 12933573 Free article. Clinical Trial.

9

Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage.

Fijnheer R, Modderman PW, Veldman H, Ouwehand WH, Nieuwenhuis HK, Roos D, de Korte D. Fijnheer R, et al. Transfusion. 1990 Jan;30(1):20-5. doi: 10.1046/j.1537-2995.1990.30190117623.x. Transfusion. 1990. PMID: 1688666

10

Soluble P-selectin as parameter for platelet activation during storage.

Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CW, de Korte D. Kostelijk EH, et al. Among authors: fijnheer r. Thromb Haemost. 1996 Dec;76(6):1086-9. Thromb Haemost. 1996. PMID: 8972035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page